- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 473/02 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6
Patent holdings for IPC class C07D 473/02
Total number of patents in this class: 64
10-year publication summary
5
|
1
|
3
|
4
|
0
|
5
|
7
|
5
|
3
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
4 |
Chengdu Baiyu Pharmaceutical Co., Ltd. | 69 |
4 |
Centre National de La Recherche Scientifique | 9632 |
3 |
Universite de Strasbourg | 646 |
3 |
Board of Regents, The University of Texas System | 5370 |
2 |
Chiesi Farmaceutici S.p.A. | 940 |
2 |
Emory University | 1498 |
2 |
Syddansk Universitet | 157 |
2 |
UCB Pharma S.A. | 280 |
2 |
Teon Therapeutics, Inc. | 27 |
2 |
Hao, Xiujuan | 9 |
2 |
Boehringer Ingelheim International GmbH | 4629 |
1 |
Agency for Science, Technology and Research | 3512 |
1 |
Takeda Pharmaceutical Company Limited | 2961 |
1 |
Millennium Pharmaceuticals, Inc. | 488 |
1 |
University of Florida Research Foundation, Inc. | 3883 |
1 |
Adenosine Therapeutics, LLC | 9 |
1 |
Biogen Idec MA Inc. | 240 |
1 |
Dr. Reddy's Laboratories, Inc. | 207 |
1 |
Dr. Reddy's Laboratories Limited | 551 |
1 |
Other owners | 27 |